{"name": "Cerevast Therapeutics",
 "permalink": "cerevast-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/cerevast-therapeutics",
 "homepage_url": "http://cerevast.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "cerevast@cerevast.com",
 "phone_number": "425-821-1939",
 "description": "",
 "created_at": "Wed May 29 12:52:36 UTC 2013",
 "updated_at": "Wed May 29 12:52:35 UTC 2013",
 "overview": "\u003Cp\u003ECerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. This non-invasive treatment is administered with Cerevast\u2019s proprietary ultrasonic headframe called the ClotBust-ERTM, an operator independent device that can be rapidly and easily deployed by virtually any emergency room staff to safely administer the ultrasound energy for SonoLysis therapy.\u003C/p\u003E\n\n\u003Cp\u003ECerevast was formed in September of 2009 following the acquisition of substantially all of the assets of ImaRx Therapeutics, Inc. \u2013 a publicly traded company focused on the development of microsphere contrast agents and therapeutics. Through this acquisition, Cerevast gained title to the dominant intellectual property estate and an extensive data package of pre-clinical and clinical studies.\u003C/p\u003E\n\n\u003Cp\u003ECerevast has assembled a management team with extensive technical, scientific, commercial and regulatory expertise. The company has also assembled a Scientific Advisory Board comprised of globally recognized clinicians, all of whom are leading experts in the field of SonoLysis, ultrasound development and stroke treatment.\u003C/p\u003E\n\n\u003Cp\u003EThe company\u2019s headquarters are located in Redmond, Washington.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       25],
      "assets/images/resized/0026/8612/268612v1-max-150x150.png"],
     [[250,
       42],
      "assets/images/resized/0026/8612/268612v1-max-250x250.png"],
     [[363,
       62],
      "assets/images/resized/0026/8612/268612v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Bradford",
      "last_name": "A. Zakes",
      "permalink": "bradford-a-zakes",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.48M",
 "funding_rounds":
  [{"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1472602/000114036113017019/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 1479154.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 22,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "12277 134th Court NE",
    "address2": "Suite 110",
    "zip_code": "98052",
    "city": "Redmond",
    "state_code": "WA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        112],
       "assets/images/resized/0026/8611/268611v1-max-150x150.png"],
      [[250,
        187],
       "assets/images/resized/0026/8611/268611v1-max-250x250.png"],
      [[450,
        337],
       "assets/images/resized/0026/8611/268611v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}